Managing Cancer Pain in Patients With Opioid Use Disorder or Nonmedical Opioid Use

Affiliations

Comment

Joseph Arthur et al. JAMA Oncol. 2022.

. 2022 Aug 1;8(8):1104-1105.

doi: 10.1001/jamaoncol.2022.2150.

¹ Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

No abstract available

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Consensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder.
Fitzgerald Jones K, Khodyakov D, Arnold R, Bulls H, Dao E, Kapo J, Meier D, Paice J, Liebschutz J, Ritchie C, Merlin J. Fitzgerald Jones K, et al. JAMA Oncol. 2022 Aug 1;8(8):1107-1114. doi: 10.1001/jamaoncol.2022.2191. JAMA Oncol. 2022. PMID: 35771550 Free PMC article.

1. Fitzgerald Jones K, Khodyakov D, Arnold R, et al. Consensus-based guidance on opioid management in individuals with advanced cancer-related pain and opioid misuse or use disorder. JAMA Oncol. Published online June 30, 2022. doi: 10.1001/jamaoncol.2022.2191 - DOI - PMC - PubMed
1. Dalal S, Bruera E. Pain management for patients with advanced cancer in the opioid epidemic era. Am Soc Clin Oncol Educ Book. 2019;39:24–35. doi: 10.1200/EDBK_100020 - DOI - PubMed
1. Arthur J, Bruera E. Balancing opioid analgesia with the risk of nonmedical opioid use in patients with cancer. Nat Rev Clin Oncol. 2019;16(4):213–226. doi: 10.1038/s41571-018-0143-7 - DOI - PubMed
1. Yennurajalingam S, Arthur J, Reddy S, et al. Frequency of and factors associated with nonmedical opioid use behavior among patients with cancer receiving opioids for cancer pain. JAMA Oncol. 2021;7(3):404–411. doi: 10.1001/jamaoncol.2020.6789 - DOI - PMC - PubMed
1. Tang M, Arthur J, Reddy A, Bruera E. Deficiencies with the Use of Prescription Drug Monitoring Program in cancer pain management: a report of two cases. J Palliat Med. 2021;24(5):751–754. doi: 10.1089/jpm.2020.0537 - DOI - PubMed